These factors, such as Bcl-2, NFκB, MAP3K7, TNF-α, and IL-1β, somewhat inhibit apoptosis of CD4+ T cells, which might then interact with B cells and afford an opportunity to clinically relapse in NMO patients. This evidence concerns the gene CD4 and neuromyelitis optica.